Table 1.
Baseline Characteristics of Study Cohort.
| Pilot (n = 43) | Control (n = 65) | P value | |
|---|---|---|---|
| Home dialysis modality of choice | |||
| PD | 30 | 65 | .0001 |
| HHD | 13 | 0 | |
| Age (mean, SD) | 64 (15) | 64 (14) | .915 |
| Male | 28 (65%) | 40 (62%) | .706 |
| Race/ethnicity: Caucasian | 21 (49%) | 32 (49%) | .968 |
| Treatment modality prior to enrollment | |||
| Predialysis | 28 (65%) | 54 (83%) | .033 |
| Previous transplant | 1 (2%) | 2 (3%) | |
| Facility-based hemodialysis | 13 (31%) | 9 (14%) | |
| Peritoneal dialysis | 1 (2%) | 0 | |
| Among predialysis patients | |||
| eGFR (mean, SD) | 14.2 (5.0) | 12.9 (4.8) | .270 |
| CKD stage 4 | 11 (39%) | 19 (35%) | .715 |
| CKD stage 5 | 17 (61%) | 35 (65%) | |
| 2-year KFRE risk | 23.1% [12.7%, 50.3%] |
30.2% [15.3%, 53.7%] |
.38 |
Note. PD = peritoneal dialysis; HHD = home hemodialysis; eGFR = estimated glomerular filtration rate; CKD = chronic kidney disease.